An antibiotic already in use in Europe to treat pneumonia controlled deadly bloodstream infections with Staphylococcus aureus bacteria just as effectively as the most powerful antibiotic currently in use, according to data from a late-stage trial.
Japan: A recent case study published in the Journal of the American Medical Association (JAMA) describes the case of a patient with subscapularis pyomyositis who developed black tongue discolouration.
Worldwide, researchers estimate Staphylococcus aureus was linked to more than 1 million deaths, while four more pathogens were associated with more than 500,000 deaths each.